New Family Medicine services being offered at IMMUNOe in Thornton! Schedule your appointment at 303.225.0080

IG Therapy For Immune Deficiencies

IGIV, is the acronym for “immune globulins intravenous,” disease-fighting antibodies released into the bloodstream, that are extracted and purified from large donor pools. After a comprehensive patient evaluation, IGIV is administered to patients who cannot produce sufficient amounts of their own antibodies and whose immune systems have been compromised. Immunoglobulins can also be given subcutaneously, SCIG. You and your doctor will determine which delivery method works best for you and your needs.

Immune Replacement:

IGIV therapy is used as replacement therapy for primary immune deficiency patients. This improves their quality of life by reducing the number of infections and other negative side effects of the disorder.

Immune Modulation:

Studies have shown that IGIV therapy can also be used to modulate or restore balance to a dysregulated immune system for people with secondary immune deficiencies.




 

Who is a Candidate for IG therapy?

When diagnosing a patient for therapy, many factors must be taken into consideration. As part of our evaluation, we conduct a complete review of the patient’s medical history and perform a thorough physical examination.

Therapy is recommended if the patient:

  • frequently exhibits recurring illnesses
  • suffers from chronic sinus, viral, bronchial or respiratory infections
  • has recurring infections that are more severe when they return, requiring more time for recovery
  • often requires antibiotics
  • often experiences body aches and fatigue, or is listless or lethargic

 

Hereditary Angioedema (HAE)

We also focus on HAE diagnosis and treatment at our clinics.We infuse the following therapies for HAE:

– Cinryze

– Berinert

Alpha-1 Antitrypsin Deficiency

We diagnose and treat Alpha-1. We infuse:

– Prolastin

Scope of Therapies

In addition to IGIV therapy, IMMUNOe patients benefit from all the latest technology and therapeutics including Therapeutic Apherisis, Synagis ,
Remicade and Tysabri.

Therapeutic Apheresis removes disease-causing substances from the blood or specific blood cells from circulation. Approved for treating over 50 diseases.

Cutting edge biologic antibody therapies include
Remicade, intravenous gammaglobulin infusions, Xolair (anti IgE) for asthma, Synagis for RSV prevention, and advanced monoclonal antibody preparations such as Remicade, Tysabri, and Synagis designed to treat diseases such as Crohn’s, multiple sclerosis, rheumatoid arthritis and others.